Thursday, Jun 20, 2024 · SEC filings
What the smart money revealed on Jun 20
670 insider filings came in. We hid 108 planned (10b5-1) sellers and 379 people whose filings were routine, like grants and tax withholding.
Disc Medicine (IRON) Director Kevin Bitterman bought $8M
222,223 shares on the open market. Not a grant or an option exercise.
Disc Medicine (IRON) Director Mona Ashiya bought $3M
83,334 shares on the open market. Not a grant or an option exercise.
Exxon Mobil (XOM) Director Maria Dreyfus bought $2M
18,310 shares on the open market. Not a grant or an option exercise.
Aerovate Therapeutics (JBIO) Director Rajeev Shah bought $1.55M
928,110 shares on the open market. Not a grant or an option exercise.
Applied Materials (AMAT) President and CEO Gary Dickerson sold $98.6M
Not marked as a planned 10b5-1 sale. Sold 21% of the shares they held directly. Still holds 1.54M shares.
Dell Technologies (DELL) Pres. William Scannell sold $35.9M
Not marked as a planned 10b5-1 sale. Sold 67% of the shares they held directly. Still holds 115,858 shares.
BeiGene (ONC) President Xiaobin Wu sold $505K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 28 more real buys
Show 115 more real sales
13F season
Holdings as of Mar 31, 2024 were due May 15
50 funds have filed. 49 filed for the quarter before.
Biggest real insider buys, Jun 14–20
Open-market buys by officers and directors, filed in the 7 days up to Jun 20.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.